Mounjaro is the latest GLP-1 to enter the increasingly crowded and complex GLP-1 market, joining Ozempic (indicated for diabetes, 2017) and Wegovy (indicated for weight loss, 2021) among others
In most cases, the search is really about finding a lower-cost generic to replace the higher-priced Ozempic, Wegovy or Rybelsus
If the semaglutide cost with insurance is a concern, our team clarifies your financial responsibilities before treatment begins
But while people who get their GLP-1s through self-pay programs or other kinds of insurance might be able to switch products, the limited products in the Bridge program mean Medicare participants will have fewer options if manufacturers cant keep up
European journal of clinical nutrition , 72 (1), 105111